WORKING GROUP NAME: SERUM URATE - SURROGATE MARKER

Serum urate as a clinically valid surrogate in gout.
Gout is caused by an increase in blood uric acid levels that leads to deposition of uric acid crystals in the joints. These crystals can cause gout flares which manifest as severely painful swollen joints. There are two general treatment strategies, firstly to treat gout flares and secondly to lower the blood uric acid levels in order to prevent the flares from occurring in the first place. It is recommended that a certain level of uric acid in the blood is reached (<0.36mmol/l; 6mg/dl) and that if this is sustained over time the gout flares will reduce and eventually stop. The strength of this relationship between lowering blood uric acid levels and reducing gout flares is the main focus of this working group.

CO-CHAIRS

Screen Shot 2020-09-25 at 10.50.18 AM

Robin Christensen

robin.christensen@regionh.dk

Jasvinder-A-Singh-Final

Jasvinder A. Singh

jasvinder.md@gmail.com

Screen Shot 2020-09-27 at 8.19.08 AM

Lisa Stamp

lisa.stamp@cdhb.health.nz

FELLOW

Screen Shot 2020-09-27 at 8.22.29 AM

Melanie Morillon

PRP

Metter Birthe Pedersen

MEMBERSHIP:

Lisa Stamp
Jas Singh
Robin Christensen
Metter Birthe Pedersen
Martin Kennedy
Melanie Morillon
Lee Simon

Angelo Gaffo
Nicola Dalbeth
Geraldine McCarthy
William Taylor
Larry Edwards
Cesar Diaz-Torne
Peter Tugwell

Abhishek Abhishek
Helen Keen
Rebecca Grainger
Ken Saag
Sara Tedeschi
Marissa Lassere
Fernando Perez-Ruiz